A commentary on ‘Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis’

Abstract

aDepartment of Intensive Care Unit, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China bSchool of Sport Medicine and Rehabilitation, Beijing Sport University, Beijing, China cUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, USA dDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA eDepartment of Clinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University, Tianjin, China fDepartment of Graduate School, Tianjin Medical University, Tianjin, China gDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA hDepartment of Orthopaedic Surgery, Beijing Jishuitan Hospital, Fourth Clinical College of Peking University, Beijing, China iState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China jCenter for Musculoskeletal Surgery (CMSC), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt University of Berlin, and Berlin Institute of Health, Berlin, Germany Kunming Cheng and Yongbin He: These authors have contributed equally to this work and share the first authorship. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. Published online ■ ■ *Corresponding author. Address: Duke University, Durham, NC UNITED STATES. E-mail address: [email protected] (H. Wu) *Corresponding author. Address: E-mail address: [email protected] (C. Li) This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-sa/4.0/

Topics & Concepts